tiprankstipranks

Eric A Hughes Insider Profile

4 Followers
Eric A Hughes, EVP, Global R&D and Chief Medical Officer at Teva Pharmaceutical, holds 0.00 shares in Teva Pharmaceutical (Ticker: TEVA), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE). Most recently, Eric A Hughes Sold ― shares of Teva Pharmaceutical on Aug 13, 2024 for an estimated value of 782.69K.
tipranks
Eric A Hughes

Eric A Hughes
Teva Pharmaceutical (TEVA)
EVP, Global R&D and Chief Medical Officer

Not Ranked
Eric A Hughes has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Eric A Hughes does not currently own shares as a corporate insider.
A breakdown of Eric A Hughes's holdings

Insider Roles

Teva Pharmaceutical
(TEVA)
EVP, Global R&D and Chief Medical Officer
Monte Rosa Therapeutics
(GLUE)
Director
Roles that Eric A Hughes holds in companies

Most Profitable Insider Trade

Stock:
Teva Pharmaceutical
(TEVA)
Rating:Informative Sell
Date:Aug 13, 2024 - Today
Return:-1.10%
The most profitable trade made by Eric A Hughes

Eric A Hughes's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Teva Pharmaceutical
Aug 13, 2024
EVP, Global R&D and Chief Medical Officer
Informative Sell
782.69K
$0.00
Monte Rosa Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Eric A Hughes's performance on stock

Eric A Hughes insider profile FAQ

What is the percentage of profitable transactions made by Eric A Hughes?
The percentage of profitable transactions made by Eric A Hughes is ―.
    What is the average return per transaction made by Eric A Hughes?
    The average return per transaction made by Eric A Hughes is ―.
      What stocks does Eric A Hughes hold?
      Eric A Hughes holds: TEVA, GLUE stocks.
        What was Eric A Hughes’s latest transaction?
        Eric A Hughes latest transaction was an Informative Sell of $782.69K.
          What was Eric A Hughes's most profitable transaction?
          Eric A Hughes’s most profitable transaction was an Informative Sell of TEVA stock on August 13, 2024. The return on the trade was -1.10%.
            What is Eric A Hughes's role in Teva Pharmaceutical?
            Eric A Hughes's role in Teva Pharmaceutical is EVP, Global R&D and Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.